Condition
Metastatic Spinal Cord Compression
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06293157Not ApplicableRecruitingPrimary
Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease
NCT06965101Not ApplicableRecruitingPrimary
To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway
NCT05109819Not ApplicableRecruitingPrimary
Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression.
Showing all 3 trials